Specialty Areas: Pharmacogenetics, translation medicine, clinical research, biomarker discovery applied to respiratory diseases.
Chronology B.S. Biology, Springfield College, 1970; M.Ed. Education, Springfield College, 1972: Ph.D. Pharmacology, College of Medicine, University of South Florida 1979; Research Associate, Department of Respiratory Diseases, Saint Vincent Hospital, MA; Assistant Research Group Chief, Department of Pharmacology, Allergic Diseases , Hoffmann-La Roche, 1980; Group Head, Pulmonary Pharmacology, Ciba-Geigy, Switzerland 1985; Senior Clinical Program Head, Respiratory Clinical Development, Glaxo, Research Triangle Park, NC, 1989; World-Wide Director Applied Genetics – Respiratory Diseases, GlaxoSmithKline, Research Triangle Park, NC, 1998; Research Associate, Pulmonary and Critical Care Medicine, Department of Medicine, University of North Carolina, Chapel Hill, NC, 2012; Adjunct Associate Professor, School of Pharmacy, University of North Carolina, Chapel Hill, NC, 2014.
Dr. Anderson’s research interests include utilizing translational, genetic, epigenetic and biomarker approaches towards understanding the molecular basis of respiratory diseases, and defining complex disease phenotypes. Current work is directed towards chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS).
Wayne H Anderson, Ashley G Henderson, Raymond D Coakley, Brian Button, Kirby L Zeman, Neil E Alexis, David B Peden, Eduardo R Lazarowski, C William Davis, Fred Fuller, Bahjat Qaqish, Elena Bordonali, William D Bennett, Richard C Boucher. The Relationship of Mucus Concentration (Hydration) to Mucus Osmotic Pressure and Transport in Chronic Bronchitis. Am J Respir Crit Care Med 192 (2): 182-190, 2015.
Wanda K. O’Neal, Wayne Anderson, Patricia Basta, Elizabeth E. Carretta, Claire M. Doerschuk, R. Graham Barr, Eugene R. Bleeker, Stephanie Christenson, Jeffrey L. Curtis, Meilan K. Han, Nadia N. Hansel, Richard E. Kanner, Eric C. Kleerup, Fernando J. Martinez, Bruce E. Miller, Stephen P. Peters, Stephen I. Rennard, Mary Beth Scholand, Ruth Tal-Singer, Prescott G. Woodruff, David J. Couper and Sonia M. Davis. Comparison of Serum, EDTA Plasma and P100 Plasma for Luminex-Based Biomarker Multiplex Assays in Patients with Chronic Obstructive Pulmonary Disease in the SPIROMICS Study. J Translational Med 12 (9); Jan 8 on-line, 2014.
Wayne H. Anderson, PhD, Beena T Koshy, PhD, Lingkang Huang, PhD, Michael M Mosteller, PhD, Sandra W. Stinnett, Hector Ortega, MD, ScD. Genetic Analysis of Asthma Exacerbations. Annals of Allergy, Asthma and Immunol 110 (6): 416-422, 2013.
Siedlinski M, Tingley D, Lipman PJ, Cho MH, Litonjua AA, Sparrow D, Bakke P, Gulsvik A, Lomas DA, Anderson W, Kong X, Rennard SI, Beaty TH, Hokanson JE, Crapo JD, Lange C, Silverman EK. Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. Hum Genet 132 (4): 431-441, 2013.
Ortega H, Prazma C, Suruki RY, Li H, Anderson WH. Association of CHI3L1 in African-Americans with Prior History of Asthma Exacerbations and Stress. J Asthma 50 (1): 7-13, 2013.
Emily Wan MD, MPH, Weiliang Qiu PhD, Andrea Baccarelli MD, PhD, Vincent J. Carey PhD, Helene Bacherman BA, Stephen Rennard MD, Alvar Agusti MD, PhD, Wayne Anderson, PhD, David A. Lomas MD, PhD, Dawn L. DeMeo MD, MPH. Systemic Steroid Exposure Is Associated with Differential Methylation in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 186 (12): 1248-1255, 2012.
Weiliang Qiu, Vince Carey, Andrea Baccarelli, Helene Bacherman, Barbara Klanderman, Stephen Rennard, Alvar Agusti, Wayne Anderson, David Lomas, Edwin K. Silverman, Dawn L. DeMeo. Variable DNA Methylation is Associated with COPD and lung function. Am J Respir Crit Care Med 185 (4): 373-381, 2012.
Peter J Castaldi, Michael H Cho, Augusto A Litonjua, Per Bakke, Amund Gulsvik, David A Lomas, Wayne Anderson, Terri H Beaty, John E Hokanson, James D Crapo, Nan Laird, Edwin K Silverman for the COPDGene and Eclipse Investigators. The Association of Genome-Wide Significant Spirometric Loci with COPD Susceptibility. American J of Resp Cell and Mol Biol 45 (6): 1147-1153, 2011.
Sreekumar G Pilla, Xiangyang Kong, Lisa D Edwards , Michael Cho, Wayne H Anderson, Harvey Coxson, David A Lomas, Edwin K Silverman, ECLIPSE and ICGN Investigators. Loci Identified by Genome-wide Association Studies influence Different Disease-related Phenotypes in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 182 (12): 1498-1505, 2010.
Eugene R. Bleecker, MD; Harold S. Nelson, MD; Monica Kraft, MD; Jonathan Corren, MD; Deborah A. Meyers, PhD; Steven W. Yancey, MS; Wayne H. Anderson, PhD; Amanda H. Emmett, MS; Hector G. Ortega, MD, ScD. Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. Am J Respir Crit Care Med 181 (7): 676-87, 2010.
M Klotsman, T York, S Pillai, C Vargas-Irwin, S Sharma, E van den Oord, W Anderson. Pharmacogenetics of the 5-Lipoxygenase Biosynthetic Pathway and Variable Clinical Response to Montelukast. Pharmacogenetics and Genomics 17: 189-196, 2007.